AI in Caribbean Public Health: From Chronic Disease to Outbreak Response

The Caribbean's public health story is shaped by three structural facts. The region has among the highest rates of diabetes, hypertension, and obesity-related chronic disease in the Americas. It sits in a climate corridor that produces recurring outbreaks of dengue, chikungunya, Zika, and increasingly leptospirosis. And it loses an outsized share of its trained healthcare workforce to migration every year, leaving ministries of health to do more with fewer doctors, fewer nurses, and fewer specialists than the population needs.

Inside that picture, AI is not a silver bullet and it should not be sold as one. But it is one of the few interventions available right now that can extend the reach of the workforce we have, sharpen the surveillance systems we run, and shift more of the chronic disease burden into prevention rather than crisis. This article looks at where the evidence is strongest, what the early Caribbean deployments have learned, and what ministries of health and regional institutions need to do to land AI well.

The Chronic Disease Crisis Is the Main Event

Non-communicable diseases account for the majority of mortality in every CARICOM member state. The Pan American Health Organization has documented that the English-speaking Caribbean has age-standardised diabetes prevalence above 12 percent in several countries, hypertension prevalence above 30 percent across the adult population, and a rising tide of complications, end-stage renal disease, lower limb amputation, stroke, and diabetic blindness, that consume a disproportionate share of every Caribbean health budget. A patient who progresses to dialysis represents both a personal tragedy and a national fiscal event.

The places where AI moves the needle in this picture are the unglamorous ones. Patient registries that actually work. Risk stratification that flags the diabetic patient whose HbA1c has been drifting upward across the last three visits, before the kidneys are gone. Adherence support that nudges the hypertensive patient who has not picked up her amlodipine refill in six weeks. Care coordination that closes the loop between the polyclinic, the specialist clinic, and the community health worker.

None of this requires frontier AI. It requires good clinical informatics, predictive models tuned to Caribbean populations, and the institutional discipline to act on what the model surfaces. Trinidad and Tobago's chronic disease assistance programme, Barbados' polyclinic network, and Jamaica's National Health Fund all hold the data and the institutional infrastructure to make this work. The missing piece is sustained investment in the health information systems that turn that data into a living registry rather than a paper archive.

Where this has been done well outside the region, the results are not subtle. Health systems in the United Kingdom, Singapore, and several Indian states have used AI-augmented chronic disease registries to reduce avoidable hospital admissions by double-digit percentages within three years of deployment. The Caribbean has every reason to expect comparable returns.

Diabetic Retinopathy and the Polyclinic Screen

The clearest near-term AI deployment in Caribbean primary care is diabetic retinopathy screening. Diabetic retinopathy is the leading cause of preventable adult blindness in the region. The standard of care is annual retinal examination by an ophthalmologist for every diabetic patient, which the Caribbean has nowhere near enough ophthalmologists to deliver.

AI-based retinal screening tools, several of which now have regulatory clearance in the United States and Europe, can be operated in a primary care clinic by a trained nurse using a portable retinal camera. The image is analysed in seconds, and patients with referable disease are sent to the specialist while patients with normal results are reassured and scheduled for next year. The deployment evidence from India, Mexico, and Rwanda, all settings where the specialist gap looks like the Caribbean gap, shows that this approach genuinely closes the screening gap and detects sight-threatening disease earlier.

For the Caribbean, the deployment path is straightforward. Every polyclinic and major health centre in the region sees diabetic patients. A retinal camera and an AI screening tool cost a fraction of a single year's worth of avoided dialysis care for a single patient. The procurement question is whether ministries will treat this as an obvious investment or wait for the third philanthropic pilot to convince them.

Tuberculosis, Pneumonia, and the Chest X-ray Gap

The Caribbean's tuberculosis burden is lower than in many regions but it is not zero, and pneumonia remains a leading cause of hospitalisation and death across age groups. The diagnostic chest X-ray is still the workhorse first-line investigation in both cases. The radiologist who reads that X-ray is, in too many Caribbean health centres, hours or days away.

AI chest X-ray interpretation tools have reached the point where they can flag suspected tuberculosis, pneumonia, pneumothorax, and several other findings with sensitivity comparable to a trained radiologist for screening purposes. The World Health Organization has issued guidance on the use of computer-aided detection for tuberculosis screening, and several products on the market meet WHO target product profiles. Deployed at the point of imaging in a district hospital, these tools let the local clinician make the immediate management decision while the radiologist's confirmation comes later, rather than waiting on the queue. For Caribbean settings, where the ratio of imaging volume to available radiologist time is structurally constrained, this is a meaningful workflow change.

Arbovirus Outbreaks and Predictive Surveillance

The Caribbean's mosquito-borne disease story has worsened with climate change. Dengue, chikungunya, and Zika have all produced major regional outbreaks within the last decade, and the modelling on Aedes aegypti distribution suggests this will intensify. The 2024 dengue surge across CARICOM strained hospital capacity in several countries and produced fatalities that aggressive vector control and earlier clinical preparation could have prevented.

AI-based predictive surveillance for arbovirus outbreaks has been piloted in Brazil, Singapore, and Sri Lanka with documented operational value. The models combine satellite-derived rainfall and temperature data, mosquito trap counts, historical case patterns, and population mobility data to forecast where Aedes populations will surge and where clinical case loads will follow, with lead times measured in weeks rather than days. CARPHA, with its existing regional surveillance role and its data-sharing agreements across CARICOM member states, is the natural institutional home for a Caribbean implementation.

What this looks like operationally: a ministry of health receives an early-warning alert that the parish of Saint Catherine, or the district of Penal-Debe, or the parish of Saint Lucy, has a 70 percent probability of a dengue case surge in the next three weeks. Vector control teams pre-position larvicide and fogging capacity. Clinics receive guidance to expect an uptick in fever presentations and to prepare clinical pathways. Public communications go out in advance rather than after the fact. None of this is hypothetical. It is the operating model that several middle-income tropical countries have already moved to.

Hurricane-Season Health Logistics

Every Caribbean ministry of health runs a hurricane preparedness plan and every Caribbean ministry of health discovers, after the storm, that the plan did not survive contact with reality. AI logistics tools have been used in disaster response globally to do what the human coordinator cannot do at speed: optimise routing of medical supplies across damaged infrastructure, match available pharmaceutical inventory across multiple facilities to projected demand, and prioritise patient evacuation when capacity is constrained.

The 2017 Irma and Maria response, the 2019 Dorian aftermath in the Bahamas, and the 2024 Beryl response in Grenada and Saint Vincent each exposed the same coordination failures. In each case, supplies existed somewhere in the supply chain but did not reach the facility that needed them in time. AI tools that combine real-time inventory visibility with damage-aware routing and probabilistic demand forecasting have demonstrated value in comparable settings. CDEMA, working with PAHO and the national ministries of health, has the convening authority to put a regional capability in place. The technical lift is small. The institutional commitment is the gating question.

Mental Health, the Quiet Crisis

The Caribbean's mental health workforce is, in most member states, a few dozen psychiatrists serving entire national populations. Depression, anxiety, post-traumatic stress, and substance use disorders are widespread and largely untreated. Stigma compounds the access problem.

AI is not going to substitute for a psychiatrist. But it can extend the reach of the limited workforce in three specific ways. First, screening: validated digital screening tools deployed through primary care or even via SMS can identify the patients who most need referral, so the scarce specialist time goes where it matters. Second, low-acuity support: chatbot-based cognitive behavioural therapy tools, with appropriate clinical oversight, have shown modest but real benefit for mild to moderate depression and anxiety in randomised trials. Third, clinician support: AI tools that handle documentation, summarise prior visits, and flag risk indicators free up scarce specialist minutes for the clinical conversation itself.

The cautions here matter. AI mental health tools deployed without clinical oversight have produced real harm in other jurisdictions. The deployment model that works is one in which AI is a layer underneath the human clinician, not a replacement for one. The Caribbean has the opportunity to set a regional standard on this rather than importing whatever the global market happens to produce.

Data Sovereignty Is Not Optional

None of this works if Caribbean health data is treated as a free input for AI vendors based elsewhere. The patient in Mandeville, the patient in Castries, the patient in Linden has the same right to data privacy as any patient in the jurisdictions whose regulations dominate the AI conversation. Caribbean ministries of health should insist on regional data residency wherever feasible, on auditable consent flows, on clear contractual terms about how patient data may be used for model training, and on the institutional capacity to enforce those terms.

CARICOM has a model data protection bill that several member states have adopted in some form. PAHO has issued AI ethics guidance for the Americas region. The Caribbean Public Health Agency has surveillance data-sharing protocols that already address some of these questions. The pieces of a coherent regional governance framework exist. They need to be assembled, harmonised across CARICOM, and resourced with the legal and technical capacity to actually function.

What the Next Three Years Should Look Like

If Caribbean public health systems move with intent over the next three years, the achievable picture is concrete. AI-augmented chronic disease registries operating in every CARICOM member state, with measurable reductions in avoidable admissions for diabetic and hypertensive complications. Diabetic retinopathy screening available at every polyclinic and major health centre. Chest X-ray AI deployed at every district hospital. CARPHA running a regional arbovirus prediction system whose alerts drive vector control resourcing. CDEMA coordinating an AI-assisted hurricane health logistics capability. Mental health screening integrated into primary care, with AI handling the first triage and the scarce specialist time directed at the highest-need patients.

None of this requires technology that does not exist. All of it requires Caribbean ministries of health, with PAHO and CARPHA support and with regional institutional partners including CAIA, to make sustained, coordinated investment decisions. The case for doing so rests on the same arithmetic that has shaped Caribbean public health policy for decades: prevention is cheaper than treatment, primary care is cheaper than tertiary, and a workforce extended by good tools serves more patients than a workforce extended by nothing at all.

The Caribbean did not invent the technology, but it can absolutely shape how the technology lands in the region. The choice is between AI that is built for the Caribbean by Caribbean institutions in service of Caribbean patients, and AI that arrives by default, designed elsewhere, optimised for elsewhere, and indifferent to the people who actually live and work and get sick here. The first option is harder. It is also the only one worth choosing.